Friday, April 25, 2025
Home 2021

Yearly Archives: 2021

Psychedelic News

That’s it. $225 Million Raised by Atai (ATAI) Gets us Interested...

Editor / Curator -
Internet News

Smile for the camera: the dark side of China’s emotion-recognition tech...

Editor / Curator -
Tiki Hut Fund

Seven of the World’s Top Performing Stocks, Most Every Morning.

Editor / Curator -
Provention
Diabetes

Teplizumab: Can We Delay the Onset of Type 1? (DiaTribe)

Editor / Curator -
AI Artificial Intelligence

Adding Amplitech Group (AMPG) $5.04 to Watch List.

Editor / Curator -
Hea;thLynked, Biotech Stock Review
Telehealth

Up 191%, HealthLynked (HLYK) Reporting Decent Numbers.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Aphex BioCleanse (SNST) Making Serious Headlines.

Editor / Curator -
Drones

Draganfly (DFLYF) to Deploy Aerial Sanitation Drones Over NASCAR Event.

Editor / Curator -
Danny Ritman
AI Artificial Intelligence

GBT Technologies (GTCH) Aims to Power Wearable GPS Tracker for Seniors.

Editor / Curator -
@NCI
CoronaVirus

Citius (CTXR) Expands Scientific Advisory Board. Dr. John Laffey, Expert in...

Editor / Curator -
1...91011...19Page 10 of 19

Latest article

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

All News Editor / Curator -
Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...

Gold Surges to a Record Above $3,400 as Trump threatens Fed Independence (CNBC)

All News Editor / Curator -
Gold prices broke $3,400 on Monday, hitting a new record as President Donald Trump’s threats against the...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.